Alterity Therapeutics Limited American Depositary Shares
Symbol: ATHE (NASDAQ)
4.36
▼ (-8.40%) -0.400
Company Description:
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
Key Stats
- Today's Open: $4.71
- Today's High: $4.72
- Today's Low: $4.36
- Today's Volume: 31.81K
- Yesterday Close: $4.76
- Yesterday High: $4.94
- Yesterday Low: $4.6
- Yesterday Volume: 24.33K
- Last Min Volume: 0
- Last Min High: $4.398
- Last Min Low: $4.36
- Last Min VWAP: $0
Company Profile
- Name: Alterity Therapeutics Limited American Depositary Shares
- Website: https://www.alteritytherapeutics.com
- Listed Date: 1992-03-04
- Location: ,
- Market Status: Active
- CIK Number: 0001131343
- SIC Code:
- SIC description:
- Market Cap: $86.28M
- Round Lot: 100
- Outstanding Shares: 18.13M
- Asset Type: ADRC
RECENT FILINGS FOR ATHE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 6-K | View |
| 2025-10-15 | 6-K | View |
| 2025-10-09 | 6-K | View |
| 2025-10-02 | 6-K | View |
| 2025-09-23 | 6-K | View |
| 2025-09-17 | 6-K | View |
| 2025-09-17 | 6-K | View |
| 2025-09-17 | 6-K | View |
| 2025-09-15 | 6-K | View |
| 2025-09-15 | 6-K | View |
| 2025-09-15 | 6-K | View |
| 2025-09-08 | 6-K | View |
| 2025-09-08 | 6-K | View |
| 2025-09-04 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-08-29 | 20-F | View |
| 2025-08-22 | 6-K | View |
| 2025-08-15 | 6-K | View |
Latest News on ATHE